x

Channel Therapeutics Corp (NYSE:CHRO)

Health Care/Life Sciences • Pharmaceuticals
CIK 1919246
Company

Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company was founded in 2002 and is headquartered in Freehold, NJ.

Address
4400 Route 9 South
Suite 1000
Freehold, New Jersey 07728
Employees
None
Stock Info
Close
$2.16
Day Range
2.16 - 2.36
52 Week Range
0.45 - 3.80
Average volume
854.1K
Short Interest
84.73K (02/14/25)
% of Float Shorted
6.90%
Market Cap
$13.02M
Revenue
N/A
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.73
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman
Todd C. Davis
President, CEO, CFO, Secretary & Director
Francis P. Knuettel II
Director
Ezra M. Friedberg
Director
Richard Malamut
Director
Chia-Lin Simmons
SEC filings
DateFormEvent
19 Dec, 2024 EFFECT
11 Dec, 2024 POS AM
2 Dec, 2024 EFFECT
22 Nov, 2024 POS AM
22 Nov, 2024 POS AM
21 Nov, 2024 8-K
19 Nov, 2024 8-K12G3
18 Nov, 2024 8-K
15 Nov, 2024 4
15 Nov, 2024 4
15 Nov, 2024 4
13 Nov, 2024 424B3
13 Nov, 2024 10-Q
13 Nov, 2024 SC 13G/A
13 Nov, 2024 424B3
24 Oct, 2024 8-K
26 Sep, 2024 DEF 14A
16 Sep, 2024 4
16 Sep, 2024 4
12 Sep, 2024 4
9 Sep, 2024 PRE 14A
13 Aug, 2024 424B3
13 Aug, 2024 10-Q
13 Aug, 2024 424B3
7 Aug, 2024 8-K
6 Aug, 2024 424B3
6 Aug, 2024 D
6 Aug, 2024 EFFECT
6 Aug, 2024 D
2 Aug, 2024 UPLOAD
2 Aug, 2024 CORRESP
29 Jul, 2024 424B3
29 Jul, 2024 S-1
29 Jul, 2024 424B3
29 Jul, 2024 8-K
2 Jul, 2024 3/A
2 Jul, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4/A
18 Jun, 2024 4
18 Jun, 2024 4
15 May, 2024 424B3
15 May, 2024 424B3
15 May, 2024 10-Q
17 Apr, 2024 424B3
17 Apr, 2024 424B3
17 Apr, 2024 POS EX
16 Apr, 2024 10-K
15 Apr, 2024 S-8
9 Apr, 2024 8-K
1 Apr, 2024 NT 10-K
21 Mar, 2024 8-K
18 Mar, 2024 8-K CEO Change
13 Mar, 2024 8-K
12 Mar, 2024 4/A
4 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
1 Mar, 2024 SC 13G
26 Feb, 2024 SC 13D
23 Feb, 2024 4
23 Feb, 2024 4
23 Feb, 2024 4
22 Feb, 2024 8-K
20 Feb, 2024 424B4 IPO completed
20 Feb, 2024 424B4
20 Feb, 2024 SEC STAFF
16 Feb, 2024 POS EX
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 CERT
15 Feb, 2024 3
15 Feb, 2024 3
15 Feb, 2024 8-A12B
15 Feb, 2024 3
14 Feb, 2024 S-1/A
14 Feb, 2024 EFFECT
12 Feb, 2024 CORRESP
12 Feb, 2024 CORRESP
12 Feb, 2024 FWP
12 Feb, 2024 S-1/A
7 Feb, 2024 FWP
7 Feb, 2024 S-1/A
31 Jan, 2024 FWP
30 Jan, 2024 CORRESP
30 Jan, 2024 S-1/A
25 Jan, 2024 UPLOAD
23 Jan, 2024 SEC STAFF
16 Jan, 2024 S-1/A
8 Nov, 2023 FWP
8 Nov, 2023 S-1/A
25 Oct, 2023 S-1/A
24 Oct, 2023 UPLOAD
16 Oct, 2023 FWP
16 Oct, 2023 S-1/A
13 Oct, 2023 CORRESP
12 Sep, 2023 UPLOAD
1 Sep, 2023 CORRESP
1 Sep, 2023 S-1/A
24 Jul, 2023 CORRESP
20 Jul, 2023 S-1/A
10 Jul, 2023 UPLOAD
30 Jun, 2023 S-1/A
30 Jun, 2023 CORRESP
19 May, 2023 UPLOAD
1 May, 2023 CORRESP
1 May, 2023 S-1/A
23 Jan, 2023 UPLOAD
20 Jan, 2023 S-1/A
11 Jan, 2023 S-1
11 Jan, 2023 CORRESP
31 Oct, 2022 UPLOAD
17 Oct, 2022 DRS/A
14 Oct, 2022 DRSLTR
3 Oct, 2022 UPLOAD
6 Sep, 2022 DRS
Last update:2025-03-06 12:06:01.681745
Channel Therapeutics Corp by TradingView

Sign Up to Subscribe